Long-term oncologic outcomes of robotic low anterior resection for rectal cancer

Eun Jung Park, Min Soo Cho, Se-Jin Baek, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Objective: The aim of this study is to evaluate long-term oncologic outcomes of robotic surgery for rectal cancer compared with laparoscopic surgery at a single institution. Background: Robotic surgery is regarded as a new modality to surpass the technical limitations of conventional surgery. Short-term outcomes of robotic surgery for rectal cancer were acceptable in previous reports. However, evidence of long-term feasibility and oncologic safety is required. Methods: Between April 2006 and August 2011, 217 patients who underwent minimally invasive surgery for rectal cancer with stage I-III disease were enrolled prospectively (robot, n = 133; laparoscopy, n = 84). Median follow-up period was 58 months (range, 4-80 months). Perioperative clinicopathologic outcomes, morbidities, 5-year survival rates, prognostic factors, and cost were evaluated. Results: Perioperative clinicopathologic outcomes demonstrated no significant differences except for the conversion rate and length of hospital stay. The 5-year overall survival rate was 92.8% in robotic, and 93.5% in laparoscopic surgical procedures (P = 0.829). The 5-year disease-free survival rate was 81.9% and 78.7%, respectively (P = 0.547). Local recurrence was similar: 2.3% and 1.2% (P = 0.649). According to the univariate analysis, this type of surgical approach was not a prognostic factor for long-term survival. The patient's mean payment for robotic surgery was approximately 2.34 times higher than laparoscopic surgery. Conclusions: No significant differences were found in the 5-year overall, disease-free survival and local recurrence rates between robotic and laparoscopic surgical procedures.We concluded that robotic surgery for rectal cancer failed to offer any oncologic or clinical benefits as compared with laparoscopy despite an increased cost.

Original languageEnglish
Pages (from-to)129-137
Number of pages9
JournalAnnals of surgery
Volume261
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1
Externally publishedYes

Fingerprint

Robotics
Rectal Neoplasms
Laparoscopy
Survival Rate
Disease-Free Survival
Length of Stay
Costs and Cost Analysis
Recurrence
Minimally Invasive Surgical Procedures
Morbidity
Safety
Survival

Keywords

  • Laparoscopic surgery
  • Oncologic outcome
  • Rectal cancer
  • Robotic surgery
  • Total mesorectal excision

ASJC Scopus subject areas

  • Surgery

Cite this

Park, E. J., Cho, M. S., Baek, S-J., Hur, H., Min, B. S., Baik, S. H., ... Kim, N. K. (2015). Long-term oncologic outcomes of robotic low anterior resection for rectal cancer. Annals of surgery, 261(1), 129-137. https://doi.org/10.1097/SLA.0000000000000613

Long-term oncologic outcomes of robotic low anterior resection for rectal cancer. / Park, Eun Jung; Cho, Min Soo; Baek, Se-Jin; Hur, Hyuk; Min, Byung Soh; Baik, Seung Hyuk; Lee, Kang Young; Kim, Nam Kyu.

In: Annals of surgery, Vol. 261, No. 1, 01.01.2015, p. 129-137.

Research output: Contribution to journalArticle

Park, EJ, Cho, MS, Baek, S-J, Hur, H, Min, BS, Baik, SH, Lee, KY & Kim, NK 2015, 'Long-term oncologic outcomes of robotic low anterior resection for rectal cancer', Annals of surgery, vol. 261, no. 1, pp. 129-137. https://doi.org/10.1097/SLA.0000000000000613
Park, Eun Jung ; Cho, Min Soo ; Baek, Se-Jin ; Hur, Hyuk ; Min, Byung Soh ; Baik, Seung Hyuk ; Lee, Kang Young ; Kim, Nam Kyu. / Long-term oncologic outcomes of robotic low anterior resection for rectal cancer. In: Annals of surgery. 2015 ; Vol. 261, No. 1. pp. 129-137.
@article{2e55b79d937e48c6a66ea9632924b26e,
title = "Long-term oncologic outcomes of robotic low anterior resection for rectal cancer",
abstract = "Objective: The aim of this study is to evaluate long-term oncologic outcomes of robotic surgery for rectal cancer compared with laparoscopic surgery at a single institution. Background: Robotic surgery is regarded as a new modality to surpass the technical limitations of conventional surgery. Short-term outcomes of robotic surgery for rectal cancer were acceptable in previous reports. However, evidence of long-term feasibility and oncologic safety is required. Methods: Between April 2006 and August 2011, 217 patients who underwent minimally invasive surgery for rectal cancer with stage I-III disease were enrolled prospectively (robot, n = 133; laparoscopy, n = 84). Median follow-up period was 58 months (range, 4-80 months). Perioperative clinicopathologic outcomes, morbidities, 5-year survival rates, prognostic factors, and cost were evaluated. Results: Perioperative clinicopathologic outcomes demonstrated no significant differences except for the conversion rate and length of hospital stay. The 5-year overall survival rate was 92.8{\%} in robotic, and 93.5{\%} in laparoscopic surgical procedures (P = 0.829). The 5-year disease-free survival rate was 81.9{\%} and 78.7{\%}, respectively (P = 0.547). Local recurrence was similar: 2.3{\%} and 1.2{\%} (P = 0.649). According to the univariate analysis, this type of surgical approach was not a prognostic factor for long-term survival. The patient's mean payment for robotic surgery was approximately 2.34 times higher than laparoscopic surgery. Conclusions: No significant differences were found in the 5-year overall, disease-free survival and local recurrence rates between robotic and laparoscopic surgical procedures.We concluded that robotic surgery for rectal cancer failed to offer any oncologic or clinical benefits as compared with laparoscopy despite an increased cost.",
keywords = "Laparoscopic surgery, Oncologic outcome, Rectal cancer, Robotic surgery, Total mesorectal excision",
author = "Park, {Eun Jung} and Cho, {Min Soo} and Se-Jin Baek and Hyuk Hur and Min, {Byung Soh} and Baik, {Seung Hyuk} and Lee, {Kang Young} and Kim, {Nam Kyu}",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/SLA.0000000000000613",
language = "English",
volume = "261",
pages = "129--137",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Long-term oncologic outcomes of robotic low anterior resection for rectal cancer

AU - Park, Eun Jung

AU - Cho, Min Soo

AU - Baek, Se-Jin

AU - Hur, Hyuk

AU - Min, Byung Soh

AU - Baik, Seung Hyuk

AU - Lee, Kang Young

AU - Kim, Nam Kyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: The aim of this study is to evaluate long-term oncologic outcomes of robotic surgery for rectal cancer compared with laparoscopic surgery at a single institution. Background: Robotic surgery is regarded as a new modality to surpass the technical limitations of conventional surgery. Short-term outcomes of robotic surgery for rectal cancer were acceptable in previous reports. However, evidence of long-term feasibility and oncologic safety is required. Methods: Between April 2006 and August 2011, 217 patients who underwent minimally invasive surgery for rectal cancer with stage I-III disease were enrolled prospectively (robot, n = 133; laparoscopy, n = 84). Median follow-up period was 58 months (range, 4-80 months). Perioperative clinicopathologic outcomes, morbidities, 5-year survival rates, prognostic factors, and cost were evaluated. Results: Perioperative clinicopathologic outcomes demonstrated no significant differences except for the conversion rate and length of hospital stay. The 5-year overall survival rate was 92.8% in robotic, and 93.5% in laparoscopic surgical procedures (P = 0.829). The 5-year disease-free survival rate was 81.9% and 78.7%, respectively (P = 0.547). Local recurrence was similar: 2.3% and 1.2% (P = 0.649). According to the univariate analysis, this type of surgical approach was not a prognostic factor for long-term survival. The patient's mean payment for robotic surgery was approximately 2.34 times higher than laparoscopic surgery. Conclusions: No significant differences were found in the 5-year overall, disease-free survival and local recurrence rates between robotic and laparoscopic surgical procedures.We concluded that robotic surgery for rectal cancer failed to offer any oncologic or clinical benefits as compared with laparoscopy despite an increased cost.

AB - Objective: The aim of this study is to evaluate long-term oncologic outcomes of robotic surgery for rectal cancer compared with laparoscopic surgery at a single institution. Background: Robotic surgery is regarded as a new modality to surpass the technical limitations of conventional surgery. Short-term outcomes of robotic surgery for rectal cancer were acceptable in previous reports. However, evidence of long-term feasibility and oncologic safety is required. Methods: Between April 2006 and August 2011, 217 patients who underwent minimally invasive surgery for rectal cancer with stage I-III disease were enrolled prospectively (robot, n = 133; laparoscopy, n = 84). Median follow-up period was 58 months (range, 4-80 months). Perioperative clinicopathologic outcomes, morbidities, 5-year survival rates, prognostic factors, and cost were evaluated. Results: Perioperative clinicopathologic outcomes demonstrated no significant differences except for the conversion rate and length of hospital stay. The 5-year overall survival rate was 92.8% in robotic, and 93.5% in laparoscopic surgical procedures (P = 0.829). The 5-year disease-free survival rate was 81.9% and 78.7%, respectively (P = 0.547). Local recurrence was similar: 2.3% and 1.2% (P = 0.649). According to the univariate analysis, this type of surgical approach was not a prognostic factor for long-term survival. The patient's mean payment for robotic surgery was approximately 2.34 times higher than laparoscopic surgery. Conclusions: No significant differences were found in the 5-year overall, disease-free survival and local recurrence rates between robotic and laparoscopic surgical procedures.We concluded that robotic surgery for rectal cancer failed to offer any oncologic or clinical benefits as compared with laparoscopy despite an increased cost.

KW - Laparoscopic surgery

KW - Oncologic outcome

KW - Rectal cancer

KW - Robotic surgery

KW - Total mesorectal excision

UR - http://www.scopus.com/inward/record.url?scp=84927170070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927170070&partnerID=8YFLogxK

U2 - 10.1097/SLA.0000000000000613

DO - 10.1097/SLA.0000000000000613

M3 - Article

VL - 261

SP - 129

EP - 137

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -